Bactiguard Holding AB
STO:BACTI B

Watchlist Manager
Bactiguard Holding AB Logo
Bactiguard Holding AB
STO:BACTI B
Watchlist
Price: 35.9 SEK Market Closed
Market Cap: 1.3B SEK
Have any thoughts about
Bactiguard Holding AB?
Write Note

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Bactiguard Holding AB

Revenue
255m SEK
Cost of Revenue
-133.8m SEK
Gross Profit
121.2m SEK
Operating Expenses
-170.6m SEK
Operating Income
-49.4m SEK
Other Expenses
-6.7m SEK
Net Income
-56.1m SEK

Margins Comparison
Bactiguard Holding AB Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
SE
Bactiguard Holding AB
STO:BACTI B
1.3B SEK
48%
-19%
-22%
JP
Hoya Corp
TSE:7741
7.1T JPY
86%
28%
24%
CH
Alcon AG
SIX:ALC
38.2B CHF
55%
13%
11%
DK
Coloplast A/S
CSE:COLO B
198.2B DKK
68%
27%
19%
US
Align Technology Inc
NASDAQ:ALGN
16.1B USD
70%
17%
11%
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
53.3B CNY
73%
46%
42%
UK
ConvaTec Group PLC
LSE:CTEC
5.3B GBP
56%
13%
7%
CA
Bausch + Lomb Corp
NYSE:BLCO
7B USD
61%
4%
-8%
CH
Ypsomed Holding AG
SIX:YPSN
5.5B CHF
34%
16%
14%
US
Merit Medical Systems Inc
NASDAQ:MMSI
5.9B USD
47%
12%
9%
US
Lantheus Holdings Inc
NASDAQ:LNTH
5.5B USD
65%
32%
29%
Country SE
Market Cap 1.3B SEK
Gross Margin
48%
Operating Margin
-19%
Net Margin
-22%
Country JP
Market Cap 7.1T JPY
Gross Margin
86%
Operating Margin
28%
Net Margin
24%
Country CH
Market Cap 38.2B CHF
Gross Margin
55%
Operating Margin
13%
Net Margin
11%
Country DK
Market Cap 198.2B DKK
Gross Margin
68%
Operating Margin
27%
Net Margin
19%
Country US
Market Cap 16.1B USD
Gross Margin
70%
Operating Margin
17%
Net Margin
11%
Country CN
Market Cap 53.3B CNY
Gross Margin
73%
Operating Margin
46%
Net Margin
42%
Country UK
Market Cap 5.3B GBP
Gross Margin
56%
Operating Margin
13%
Net Margin
7%
Country CA
Market Cap 7B USD
Gross Margin
61%
Operating Margin
4%
Net Margin
-8%
Country CH
Market Cap 5.5B CHF
Gross Margin
34%
Operating Margin
16%
Net Margin
14%
Country US
Market Cap 5.9B USD
Gross Margin
47%
Operating Margin
12%
Net Margin
9%
Country US
Market Cap 5.5B USD
Gross Margin
65%
Operating Margin
32%
Net Margin
29%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Bactiguard Holding AB Competitors

Country Company Market Cap ROE ROA ROCE ROIC
SE
Bactiguard Holding AB
STO:BACTI B
1.3B SEK
-14%
-8%
-9%
-8%
JP
Hoya Corp
TSE:7741
7.1T JPY
20%
16%
22%
28%
CH
Alcon AG
SIX:ALC
38.2B CHF
5%
4%
5%
5%
DK
Coloplast A/S
CSE:COLO B
198.2B DKK
29%
11%
21%
13%
US
Align Technology Inc
NASDAQ:ALGN
16.1B USD
11%
7%
16%
9%
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
53.3B CNY
25%
23%
27%
38%
UK
ConvaTec Group PLC
LSE:CTEC
5.3B GBP
9%
4%
9%
7%
CA
Bausch + Lomb Corp
NYSE:BLCO
7B USD
-5%
-3%
2%
2%
CH
Ypsomed Holding AG
SIX:YPSN
5.5B CHF
13%
8%
14%
9%
US
Merit Medical Systems Inc
NASDAQ:MMSI
5.9B USD
9%
6%
8%
7%
US
Lantheus Holdings Inc
NASDAQ:LNTH
5.5B USD
46%
24%
36%
35%
Country SE
Market Cap 1.3B SEK
ROE
-14%
ROA
-8%
ROCE
-9%
ROIC
-8%
Country JP
Market Cap 7.1T JPY
ROE
20%
ROA
16%
ROCE
22%
ROIC
28%
Country CH
Market Cap 38.2B CHF
ROE
5%
ROA
4%
ROCE
5%
ROIC
5%
Country DK
Market Cap 198.2B DKK
ROE
29%
ROA
11%
ROCE
21%
ROIC
13%
Country US
Market Cap 16.1B USD
ROE
11%
ROA
7%
ROCE
16%
ROIC
9%
Country CN
Market Cap 53.3B CNY
ROE
25%
ROA
23%
ROCE
27%
ROIC
38%
Country UK
Market Cap 5.3B GBP
ROE
9%
ROA
4%
ROCE
9%
ROIC
7%
Country CA
Market Cap 7B USD
ROE
-5%
ROA
-3%
ROCE
2%
ROIC
2%
Country CH
Market Cap 5.5B CHF
ROE
13%
ROA
8%
ROCE
14%
ROIC
9%
Country US
Market Cap 5.9B USD
ROE
9%
ROA
6%
ROCE
8%
ROIC
7%
Country US
Market Cap 5.5B USD
ROE
46%
ROA
24%
ROCE
36%
ROIC
35%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More
Back to Top